Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 445Other hematologic neoplasm 419Myeloid 105Sarcoma 62Breast 62Plasma cell 39CNS 39Classical hematology 34Genitourinary 27Dermatologic 25Head & Neck 13Gynecologic 12Other neoplasm 5Thoracic 4Other solid neoplasm 4Gastrointestinal 4Tumor-Agnostic 3Other 3

Conditions

Mucositis 3Osteosarcoma 1Neurotoxicity Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia 1

Interventions

Exercise 28Metformin 24Surveys and Questionnaires 19Radiotherapy 14Methods 14Early Intervention, Educational 13Counseling 13Educational Status 12naloxegol 10Standard of Care 10Tirzepatide 9Nutrition Assessment 9Diet Therapy 9Cisplatin 9Resistance Training 8Psychiatric Rehabilitation 8Diet 8Therapeutics 7Interviews as Topic 7alvimopan 6Liraglutide 6Fibroblast Growth Factor 7 6Caloric Restriction 6semaglutide 5Radiation 5Low-Level Light Therapy 5Injections 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Methotrexate × Other × Clear all
NCT01085617 2025-03-30

UKALL14

University College, London

Completed
OtherOther hematologic neoplasm

Leukemia, Mucositis

NCT02022358 2015-06-04

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

University College, London

Phase 2 Terminated
34 enrolled
OtherSarcoma

Osteosarcoma, Mucositis

NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡